1 From the Child Development and Mental Retardation Center and Department of Pediatrics, University of Washington School of Medicine, Seattle, WA
2 From the Division of Genetics/Dysmorphology, Department of Pediatrics, College of Medicine, University of Arizona, Tucson, AZ
3 From the Division of Genetics, Department of Pediatrics and Pathology, Vanderbilt University Medical Center, Nashville, TN
4 From the The Rehabilitation Institute, Pittsburgh, PA
5 From the Division of Developmental Disabilities and The Iowa Child Health Specialty Clinics, Department of Pediatrics, The University of Iowa Hospitals and Clinics, Iowa City, IA
6 From the Department of Pediatrics, St Louis University School of Medicine, St Louis, MO
7 From the Institute for Molecular Genetics and Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX
The diagnosis of Prader-Willi syndrome (PWS) is based on clinical findings that change with age. Hypotonia is prominent in infancy. Obesity, mild mental retardation or learning disability, and behavior problems, especially in association with food and eating result in a debilitating physical and developmental disability in adolescence and adulthood. No consistent biological marker is yet available for PWS in spite of recent research activity in cytogenetics and molecular genetics. Diagnostic criteria for PWS were developed by consensus of seven clinicians experienced with the syndrome in consultation with national and international experts. Two scoring systems are provided: one for children aged 0 to 36 months and another one for children aged 3 years to adults. These criteria will aid in recognition of the syndrome in hypotonic infants and in obese, mildly retarded, behaviorally disturbed adolescents and adults. They will also ensure uniform diagnosis for future clinical and laboratory research in PWS.
Key Words: Prader-Willi syndrome diagnostic criteria
Submitted on May 8, 1992
Accepted on August 20, 1992
This article has been cited by other articles:
![]() |
T. Odent, F. Accadbled, G. Koureas, M. Cournot, A. Moine, G. Diene, C. Molinas, G. Pinto, M. Tauber, B. Gomes, et al. Scoliosis in Patients With Prader-Willi Syndrome Pediatrics, August 1, 2008; 122(2): e499 - e503. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Feigerlova, G. Diene, F. Conte-Auriol, C. Molinas, I. Gennero, J.-P. Salles, C. Arnaud, and M. Tauber Hyperghrelinemia Precedes Obesity in Prader-Willi Syndrome J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2800 - 2805. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. A. de Lind van Wijngaarden, B. J. Otten, D. A. M. Festen, K. F. M. Joosten, F. H. de Jong, F. C. G. J. Sweep, and A. C. S. Hokken-Koelega High Prevalence of Central Adrenal Insufficiency in Patients with Prader-Willi Syndrome J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1649 - 1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chen, J. Visootsak, S. Dills, and J. M. Graham JR Prader-Willi Syndrome: An Update and Review for the Primary Pediatrician Clinical Pediatrics, September 1, 2007; 46(7): 580 - 591. [Abstract] [PDF] |
||||
![]() |
P. Marzullo, C. Marcassa, R. Campini, E. Eleuteri, A. Minocci, A. Sartorio, R. Vettor, A. Liuzzi, and G. Grugni Conditional Cardiovascular Response to Growth Hormone Therapy in Adult Patients with Prader-Willi Syndrome J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1364 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Minihan, S. N. Fitch, and A. Must What Does the Epidemic of Childhood Obesity Mean for Children with Special Health Care Needs? J. Law Med. Ethics, March 1, 2007; 35(1): 61 - 77. [PDF] |
||||
![]() |
K. Yamada, H. Matsuzawa, M. Uchiyama, I. L. Kwee, and T. Nakada Brain Developmental Abnormalities in Prader-Willi Syndrome Detected by Diffusion Tensor Imaging Pediatrics, August 1, 2006; 118(2): e442 - e448. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wei, X. Qi, J. Reed, J. Ceci, H.-Q. Wang, G. Wang, E. W. Englander, and G. H. Greeley Jr. Effect of chronic hyperghrelinemia on ingestive action of ghrelin Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R803 - R808. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Johnstone, A. J. DuBose, C. R. Futtner, M. D. Elmore, C. I. Brannan, and J. L. Resnick A human imprinting centre demonstrates conserved acquisition but diverged maintenance of imprinting in a mouse model for Angelman syndrome imprinting defects Hum. Mol. Genet., February 1, 2006; 15(3): 393 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Marzullo, C. Marcassa, R. Campini, E. Eleuteri, A. Minocci, L. Priano, P. Temporelli, A. Sartorio, R. Vettor, A. Liuzzi, et al. The Impact of Growth Hormone/Insulin-Like Growth Factor-I Axis and Nocturnal Breathing Disorders on Cardiovascular Features of Adult Patients with Prader-Willi Syndrome J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5639 - 5646. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fronczek, G. J. Lammers, R. Balesar, U. A. Unmehopa, and D. F. Swaab The Number of Hypothalamic Hypocretin (Orexin) Neurons Is Not Affected in Prader-Willi Syndrome J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5466 - 5470. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Kuwako, A. Hosokawa, I. Nishimura, T. Uetsuki, M. Yamada, S. Nada, M. Okada, and K. Yoshikawa Disruption of the Paternal Necdin Gene Diminishes TrkA Signaling for Sensory Neuron Survival J. Neurosci., July 27, 2005; 25(30): 7090 - 7099. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pagano, O. Marin, A. Calcagno, P. Schiappelli, C. Pilon, G. Milan, M. Bertelli, E. Fanin, G. Andrighetto, G. Federspil, et al. Increased Serum Resistin in Adults with Prader-Willi Syndrome Is Related to Obesity and Not to Insulin Resistance J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4335 - 4340. [Abstract] [Full Text] [PDF] |
||||
![]() |
N A Shapira, M C Lessig, A G He, G A James, D J Driscoll, and Y Liu Satiety dysfunction in Prader-Willi syndrome demonstrated by fMRI J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 260 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-w. Kim, H.-j. Yoo, S.-c. Cho, K.-E M. Hong, and B.-n. Kim Behavioral Characteristics of Prader-Willi Syndrome in Korea: Comparison With Children With Mental Retardation and Normal Controls J Child Neurol, February 1, 2005; 20(2): 134 - 138. [Abstract] [PDF] |
||||
![]() |
S. J. Chamberlain, K. A. Johnstone, A. J. DuBose, T. A. Simon, M. S. Bartolomei, J. L. Resnick, and C. I. Brannan Evidence for genetic modifiers of postnatal lethality in PWS-IC deletion mice Hum. Mol. Genet., December 1, 2004; 13(23): 2971 - 2977. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Civardi, R. Vicentini, G. Grugni, and R. Cantello Corticospinal Physiology in Patients With Prader-Willi Syndrome: A Transcranial Magnetic Stimulation Study Arch Neurol, October 1, 2004; 61(10): 1585 - 1589. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Landers, D. L. Bancescu, E. Le Meur, C. Rougeulle, H. Glatt-Deeley, C. Brannan, F. Muscatelli, and M. Lalande Regulation of the large (~1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn Nucleic Acids Res., June 29, 2004; 32(11): 3480 - 3492. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Goldstone, E. L. Thomas, A. E. Brynes, G. Castroman, R. Edwards, M. A. Ghatei, G. Frost, A. J. Holland, A. B. Grossman, M. Korbonits, et al. Elevated Fasting Plasma Ghrelin in Prader-Willi Syndrome Adults Is Not Solely Explained by Their Reduced Visceral Adiposity and Insulin Resistance J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1718 - 1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ren, S. Lee, S. Pagliardini, M. Gerard, C. L. Stewart, J. J. Greer, and R. Wevrick Absence of Ndn, Encoding the Prader-Willi Syndrome-Deleted Gene necdin, Results in Congenital Deficiency of Central Respiratory Drive in Neonatal Mice J. Neurosci., March 1, 2003; 23(5): 1569 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Smith, J Egan, G Ridley, E Haan, P Montgomery, K Williams, and E Elliott Birth prevalence of Prader-Willi syndrome in Australia Arch. Dis. Child., March 1, 2003; 88(3): 263 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. DelParigi, M. Tschop, M. L. Heiman, A. D. Salbe, B. Vozarova, S. M. Sell, J. C. Bunt, and P. A. Tataranni High Circulating Ghrelin: A Potential Cause for Hyperphagia and Obesity in Prader-Willi Syndrome J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5461 - 5464. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Whittington, A Holland, T Webb, J Butler, D Clarke, and H Boer Relationship between clinical and genetic diagnosis of Prader-Willi syndrome J. Med. Genet., December 1, 2002; 39(12): 926 - 932. [Full Text] [PDF] |
||||
![]() |
D. J. Fidler, R. M. Hodapp, and E. M. Dykens Behavioral Phenotypes and Special Education: Parent Report of Educational Issues for Children with Down Syndrome, Prader-Willi Syndrome, and Williams Syndrome Journal of Special Education, August 1, 2002; 36(2): 80 - 88. [Abstract] [PDF] |
||||
![]() |
C. Hoybye, A. Hilding, H. Jacobsson, and M. Thoren Metabolic Profile and Body Composition in Adults with Prader-Willi Syndrome and Severe Obesity J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3590 - 3597. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Carrel, S. E. Myers, B. Y. Whitman, and D. B. Allen Benefits of Long-Term GH Therapy in Prader-Willi Syndrome: A 4-Year Study J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1581 - 1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.J. CLARKE, H. BOER, J. WHITTINGTON, A. HOLLAND, J. BUTLER, and T. WEBB Prader--Willi syndrome, compulsive and ritualistic behaviours: the first population-based survey The British Journal of Psychiatry, April 1, 2002; 180(4): 358 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P Goldstone, A. E Brynes, E L. Thomas, J. D Bell, G. Frost, A. Holland, M. A Ghatei, and S. R Bloom Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome Am. J. Clinical Nutrition, March 1, 2002; 75(3): 468 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Goldstone, U. A. Unmehopa, S. R. Bloom, and D. F. Swaab Hypothalamic NPY and Agouti-Related Protein Are Increased in Human Illness But Not in Prader-Willi Syndrome and Other Obese Subjects J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 927 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Poyatos, M Guitart, E Gabau, C Brun, M Mila, J Vaquerizo, and M D Coll Severe phenotype in Angelman syndrome resulting from paternal isochromosome 15 J. Med. Genet., February 1, 2002; 39(2): e4 - 4. [Full Text] [PDF] |
||||
![]() |
P. Burman, E. M. Ritzen, and A. C. Lindgren Endocrine Dysfunction in Prader-Willi Syndrome: A Review with Special Reference to GH Endocr. Rev., December 1, 2001; 22(6): 787 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
J E Whittington, A J Holland, T Webb, J Butler, D Clarke, and H Boer Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region J. Med. Genet., November 1, 2001; 38(11): 792 - 798. [Full Text] [PDF] |
||||
![]() |
M. Gunay-Aygun, S. Schwartz, S. Heeger, M. A. O'Riordan, and S. B. Cassidy The Changing Purpose of Prader-Willi Syndrome Clinical Diagnostic Criteria and Proposed Revised Criteria Pediatrics, November 1, 2001; 108(5): e92 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Goldstone, E. L. Thomas, A. E. Brynes, J. D. Bell, G. Frost, N. Saeed, J. V. Hajnal, J. K. Howard, A. Holland, and S. R. Bloom Visceral Adipose Tissue and Metabolic Complications of Obesity Are Reduced in Prader-Willi Syndrome Female Adults: Evidence for Novel Influences on Body Fat Distribution J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4330 - 4338. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wirth, E. Back, A. Huttenhofer, H.-G. Nothwang, C. Lich, S. Gross, C. Menzel, A. Schinzel, P. Kioschis, N. Tommerup, et al. A translocation breakpoint cluster disrupts the newly defined 3' end of the SNURF-SNRPN transcription unit on chromosome 15 Hum. Mol. Genet., February 1, 2001; 10(3): 201 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. MacDonald and D. Camp Prolonged but Reversible Respiratory Failure in a Newborn With Prader-Willi Syndrome J Child Neurol, February 1, 2001; 16(2): 153 - 154. [Abstract] [PDF] |
||||
![]() |
F. Muscatelli, D. N. Abrous, A. Massacrier, I. Boccaccio, M. L. Moal, P. Cau, and H. Cremer Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome Hum. Mol. Genet., December 1, 2000; 9(20): 3101 - 3110. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, S. Kozlov, L. Hernandez, S. J. Chamberlain, C. I. Brannan, C. L. Stewart, and R. Wevrick Expression and imprinting of MAGEL2 suggest a role in Prader-Willi syndrome and the homologous murine imprinting phenotype Hum. Mol. Genet., July 22, 2000; 9(12): 1813 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A van Mil, K. R Westerterp, W. J Gerver, L. M Curfs, C. T Schrander-Stumpel, A. D Kester, and W. H Saris Energy expenditure at rest and during sleep in children with Prader-Willi syndrome is explained by body composition Am. J. Clinical Nutrition, March 1, 2000; 71(3): 752 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. DUPONT, D. LE TESSIER, D. RABINEAU, L. CUISSET, C. VASSEUR, M. JEANPIERRE, M. DELPECH, F. PINTON, G. PONSOT, and M.-F DENAVIT Unexpected Angelman syndrome molecular defect in a girl displaying clinical features of Prader-Willi syndrome J. Med. Genet., August 1, 1999; 36(8): 652 - 654. [Full Text] |
||||
![]() |
J. G. Falls, D. J. Pulford, A. A. Wylie, and R. L. Jirtle Genomic Imprinting: Implications for Human Disease Am. J. Pathol., March 1, 1999; 154(3): 635 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Scher Topical Review: Applying Classifications of Sleep Disorders to Children With Neurologic Conditions J Child Neurol, November 1, 1998; 13(11): 525 - 536. [Abstract] [PDF] |
||||
![]() |
A. Martin, M. State, K. Koenig, R. Schultz, E. M. Dykens, S. B. Cassidy, and J. F. Leckman Prader-Willi Syndrome Am J Psychiatry, September 1, 1998; 155(9): 1265 - 1273. [Full Text] |
||||
![]() |
P S W Davies, S Evans, S Broomhead, H Clough, J M E Day, A Laidlaw, and N D Barnes Effect of growth hormone on height, weight, and body composition in Prader-Willi syndrome Arch. Dis. Child., May 1, 1998; 78(5): 474 - 476. [Abstract] [Full Text] |
||||
![]() |
B. A. Th. F. Gabreëls, D. F. Swaab, D. P. V. de Kleijn, N. G. Seidah, J.-W. Van de Loo, W. J. M. Van de Ven, G. J. M. Martens, and F. W. van Leeuwen Attenuation of the Polypeptide 7B2, Prohormone Convertase PC2, and Vasopressin in the Hypothalamus of Some Prader-Willi Patients: Indications for a Processing Defect J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 591 - 599. [Abstract] [Full Text] |
||||
![]() |
J. S. Sutcliffe, Y.-h. Jiang, R.-J. Galjaard, T. Matsuura, P. Fang, T. Kubota, S. L. Christian, J. Bressler, B. Cattanach, D. H. Ledbetter, et al. The E6-AP Ubiquitin-Protein Ligase (UBE3A) Gene Is Localized within a Narrowed Angelman Syndrome Critical Region Genome Res., April 1, 1997; 7(4): 368 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Ning, A Roschke, S L Christian, J Lesser, J S Sutcliffe, and D H Ledbetter Identification of a novel paternally expressed transcript adjacent to snRPN in the Prader-Willi syndrome critical region. Genome Res., August 1, 1996; 6(8): 742 - 746. [Abstract] [PDF] |
||||
![]() |
F. J. DiMario Jr, L. Bauer, J. Volpe, and S. B. Cassidy Respiratory Sinus Arrhythmia in Patients With Prader-Willi Syndrome J Child Neurol, March 1, 1996; 11(2): 121 - 125. [Abstract] [PDF] |
||||
![]() |
R. H.A. Ruvalcaba and V. A. Holm Effects of Growth Hormone in Prader-Willi Syndrome: A Case Report Clinical Pediatrics, May 1, 1993; 32(5): 292 - 295. [PDF] |
||||